Surgical Resection of Renal Cell Carcinoma After Targeted Therapy

Abstract

Surgical resection of renal cell carcinoma after targeted therapy is feasible with low morbidity in most patients. However, significant complications can occur, raising concern for possible compromise of tissue and/or vascular integrity associated with surgery in this setting.